Watermark
  Back to Search Results

BGB-3111-206

Completed

Study to Evaluate Efficacy and Safety of BGB-3111 in Participants With Relapsed or Refractory Mantle Cell Lymphoma (MCL)

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-3111-206

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT03206970

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20160888

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / 75 Years

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / 75 Years

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan